AI CAPITAL INTELLIGENCE
高维医药 · Pre-A · CNY 200,000,000–900,000,000 (reported range) · 2026-10-14
Financing facts, at a glance
高维医药: financing disclosed on 2026-10-14, Pre-A, CNY 200,000,000–900,000,000 (reported range). Named investors: 华泰金斯瑞基金, 东方嘉富, 国方创投, 瑞力投资, 楚昌基金, 兴华鼎立, 西湖创新, 广发信德. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
Original source 1 · Original source 2 · Original source 3 · Original source 4 · Original source 5
高维医药 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Pre-A, with an amount of CNY 200,000,000–900,000,000 (reported range). Named investors include 华泰金斯瑞基金, 东方嘉富, 国方创投, 瑞力投资, 楚昌基金, 兴华鼎立, 西湖创新, 广发信德.
- Disclosed company name
- 高维医药（杭州）有限公司
- Disclosure date
- 2026-10-14
- Round
- Pre-A
- Financing amount
- CNY 200,000,000–900,000,000 (reported range)
- Market coverage
- China
- Sector
- Industry AI / Drug discovery & life sciences
- Product form
Disclosed investors
华泰金斯瑞基金, 东方嘉富, 国方创投, 瑞力投资, 楚昌基金, 兴华鼎立, 西湖创新, 广发信德
Original sources
- Source 1 · feng.ifeng.com
- Source 2 · bydrug.pharmcube.com
- Source 3 · caifuhao.eastmoney.com
- Source 4 · vc.pedaily.cn
- Source 5 · www.163.com
Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.